Rethinking cancer detection
Research on early cancer detection has been hamstrung by market failure. We’ve got a plan to fix it.
7th October 2020
Research on early cancer detection has been hamstrung by market failure. We’ve got a plan to fix it.
7th October 2020
How society’s changing relationship with health will break down the wall between pharma brands and consumers
2nd October 2020
How artificial intelligence can help pharma companies reach new audiences
23rd September 2020
And why does it matter more than ever following COVID-19?
21st September 2020
Three ways to optimise energy consumption in pharma manufacturing
16th September 2020
How behavioural science can revolutionise training in the pharma industry
9th September 2020
Identifying and stopping COVID-19 co-infections with broader diagnostics
9th September 2020
How pharma can move digitalisation from theory to commercial reality
9th September 2020
Galapagos' Walid Abi-Saab on partnering with patients to make a meaningful difference in a rare and misunderstood condition
8th September 2020
Alternative digital solutions for pharma from other regulated industries
27th August 2020
The work pharmaceutical brands have done to overcome an inherent scepticism toward them must be nurtured and built on
20th August 2020
Pharmaceutical companies and technology have a critical role to play in closing gaps seen during COVID-19
19th August 2020
An overview of current treatments and their potential drug interactions
30th July 2020